If approved, it would be the first COVID-19 vaccine for children under five in Canada – an age group that has remained unfit for vaccination since the vaccine was introduced in late 2020. Moderna Canada submitted its candidate vaccine for children between six months and five years for review on Thursday, a spokesman told Global News. Health Canada updated the submission page on Friday, confirming receipt.
Read more: “Quebec wins battle:” Moderna announces vaccine factory in Montreal
The Moderna vaccine for children aged six to 11 was approved in March. Late last month, Moderna said a low-dose COVID-19 vaccine works for babies, toddlers and preschoolers. The story goes on under the ad The company said a test of 6,700 children showed that the vaccine was safe and produced a similar antibody response seen in adults. A single dose for children under six is 25 micrograms – about a quarter of the size given to adults and teens and half the size used for children six to 11 years old. Moderna said its vaccine was 51 percent effective in preventing symptoms in children aged six months to two years and 37 percent effective in preventing symptoms in children aged two to five years. Its application requires the vaccine to be administered in two doses, with a difference of four weeks. “We are not going to overcome this pandemic until we have the opportunity to offer protection to all Canadians. “At the moment we have a huge group of Canadians, our youngest Canadians, who do not have this opportunity,” said Dr. Katharine Smart, president of the Canadian Medical Association and pediatrician at Whitehorse, Yukon. “This will be a huge step forward and many parents will be very relieved after an incredibly long wait for this information.” 0: 47COVID-19: Trudeau Announces New Moderna Plant in Montreal, Helping Canada Expand Biosciences COVID-19: Trudeau Announces New Moderna Plant in Montreal, Helping Canada Expand Life Sciences Moderna submitted data to the US Food and Drug Administration (FDA) on Thursday that it hopes to prove that two low-dose vaccines can protect babies, infants and preschoolers – though not as effectively during the Omicron outbreak as earlier in the pandemic. Trending Stories
Are you looking for a used car? What you need to know about the thriving market Grammy-winning singer Naomi Judd has died at the age of 76
The story goes on under the ad The FDA said Friday that it had set provisional dates for June to publicly review COVID-19 vaccines for America’s youngest children, usually the last step before the country approves vaccines. Pfizer, meanwhile, is in “ongoing discussions with Health Canada about the vaccine in this population,” but could not comment on application schedules in Canada, a spokeswoman said.
Read more: Parents feel “isolated” in the 6th wave of COVID. How to protect your children
Pfizer also tries small doses for children under the age of five, but had to add a third dose to its study when two were not strong enough. “If these submissions are made sometime in May, we can expect it to take perhaps a month or two, if not more, to be reviewed,” said Dr. Omar Kahn, a professor of biomedical engineering at the University of Toronto. World News this week. “It’s safe to say that we do not know when it will be approved, but that it just needs to take time, and sometimes you may not know how much it’s because you really want to get through this data and make sure everything is perfect.” The story goes on under the ad Canada, which is on a sixth wave of COVID-19, reported 3,008 children under the age of 12 contracting the virus during the week of April 10-16. During the same period, 93 children under the age of 12 were admitted to hospital due to COVID-19. More than 1,000 Canadians aged 80 and over were admitted to hospital that week. Children are less likely to suffer from severe COVID-19 disease, but it is likely and its effects may persist in some cases, according to a recent study. If the Moderna vaccine for children under the age of five is found to be safe, Smart encourages parents with children in this age group to get it. Vaccination for five- to 11-year-olds lags behind those of Canada’s older age groups. “I have not yet seen the data for children aged six months to five, but I expect it to show safety and be approved,” he said. “If this happens, parents can feel confident that again, choosing vaccination is a way to protect their children from something they encounter in their daily lives, and vaccination is one of our best prevention tools. their rare but serious results “. – with files from Jamie Mauracher of Global News, the Canadian Press and the Associated Press © 2022 Global News, part of Corus Entertainment Inc.
